<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Transmyocardial laser revascularization improves left ventricular myocardial perfusion</title><link href="/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/d/css/icofont.min.css" rel="stylesheet"/><link href="/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/d/css/animate.css" rel="stylesheet"/><link href="/d/css/owl.carousel.css" rel="stylesheet"/><link href="/d/css/magnific-popup.css" rel="stylesheet"/><link href="/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/d/css/style.css" rel="stylesheet"/><link href="/d/css/rtl_edited.css" rel="stylesheet"/><link href="/d/css/responsive.css" rel="stylesheet"/><link href="https://medilib.ir/uptodate_assets/main.css" rel="stylesheet">
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>

<meta content="" name="description"/>
<link href="/d/img/favicon.png" rel="icon" type="image/png"/>
</link></head>
<body>
<!-- Start Main Menu Area -->

<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>




<section class="teacher-area ptb-10">
<div class="container">
</div>

<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Transmyocardial laser revascularization improves left ventricular myocardial perfusion</h1>
<div class="graphic"><div class="figure"><div class="ttl">Transmyocardial laser revascularization improves left ventricular myocardial perfusion</div><div class="cntnt"><img src="data:png;base64,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"/></div><div class="graphic_lgnd">The percentage change in myocardial perfusion is calculated as the number of defects at baseline minus the number of defects at follow-up, divided by the number of defects at baseline. Myocardial perfusion improved with transmyocardial laser revascularization (TMLR) but worsened with medical therapy; the percent change in myocardial perfusion differed significantly at each point in time of evaluation (p = 0.001 at three months, p = 0.02 at six months, and p = 0.002 at 12 months). At one year, myocardial perfusion improved by 20 percent in patients undergoing TMLR while is worsened by 27 percent in the medical treatment group.</div><div class="graphic_reference">Data from Frazier OH, March RJ, Horvath KA. N Engl J Med 1999; 341:1021.</div><div id="graphicVersion">Graphic 79231 Version 3.0</div></div></div>
</div>
</div>

</section>

</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->


<!-- End Footer Area -->
<!-- Back to top -->

<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->

<!-- Prpper JS -->

<!-- Bootstrap Min JS -->

<!-- Classy Nav Min Js -->

<!-- Owl Carousel Min Js -->

<!-- Magnific Popup JS -->

<!-- CounterUp JS -->

<!-- Waypoints JS -->

<!-- Form Validator Min JS -->

<!-- Contact Form Min JS -->

<!-- Main JS -->

<!-- Global site tag (gtag.js) - Google Analytics -->






</body>
</html>
